DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Lurasidone Hydrochloride is a drug marketed by Accord Hlthcare, Amneal Pharms Co, Emcure Pharms Ltd, Invagen Pharms, Lupin Ltd, Piramal Hlthcare Uk, Sun Pharm, Teva Pharms Usa, Torrent, Watson Labs Teva, and Zydus Pharms. and is included in eleven NDAs.
The generic ingredient in LURASIDONE HYDROCHLORIDE is lurasidone hydrochloride. There are twenty-six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the lurasidone hydrochloride profile page.
A generic version of LURASIDONE HYDROCHLORIDE was approved as lurasidone hydrochloride by ACCORD HLTHCARE on January 3rd, 2019.
Summary for LURASIDONE HYDROCHLORIDE
|Raw Ingredient (Bulk) Api Vendors:||39|
|Formulation / Manufacturing:||see details|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for LURASIDONE HYDROCHLORIDE|
|DailyMed Link:||LURASIDONE HYDROCHLORIDE at DailyMed|
Recent Clinical Trials for LURASIDONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Jayasree Basivireddy||Phase 3|
|Sumitomo Pharmaceutical (Suzhou) Co., Ltd.||Phase 3|
|Columbia University||Phase 4|